REGN:NGS-Regeneron Pharmaceuticals Inc. (USD)

EQUITY | Biotechnology | Nasdaq Global Select

Last Closing

USD 1071.12

Change

+17.09 (+1.62)%

Market Cap

USD 42.08B

Volume

0.26M

Analyst Target

USD 674.63
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Regeneron Pharmaceuticals Inc is a fully integrated biopharmaceutical company. It discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-10 )

Largest Industry Peers for Biotechnology

Symbol Name Price(Change) Market Cap
VRTX Vertex Pharmaceuticals Inc

-6.88 (-1.37%)

USD 126.85B
MRNA Moderna Inc

+0.38 (+0.32%)

USD 46.95B
ARGX argenx NV ADR

+6.66 (+1.31%)

USD 30.45B
ALNY Alnylam Pharmaceuticals Inc

+3.65 (+1.56%)

USD 29.58B
BGNE BeiGene Ltd

+9.60 (+6.12%)

USD 16.93B
RPRX Royalty Pharma Plc

-0.37 (-1.30%)

USD 16.81B
BMRN Biomarin Pharmaceutical Inc

-0.06 (-0.07%)

USD 15.97B
UTHR United Therapeutics Corporatio..

-24.25 (-7.18%)

USD 14.60B
SRPT Sarepta Therapeutics Inc

-0.80 (-0.56%)

USD 13.76B
INCY Incyte Corporation

-2.72 (-4.01%)

USD 12.98B

ETFs Containing REGN

FPXU:PA First Trust US Equity Opp.. 9.20 % 0.00 %

+0.70 (+0.82%)

USD 6.52M
EMEH:PA BNP Paribas Easy Energy &.. 8.55 % 0.00 %

+0.22 (+0.82%)

USD 0.04B
GSCU:PA BNP Paribas Easy Energy &.. 8.55 % 0.00 %

+0.27 (+0.82%)

USD 0.16B
EMEH:XETRA BNP Paribas Easy Energy &.. 8.55 % 0.00 %

+0.22 (+0.82%)

USD 0.11B
GSDE:XETRA BNP Paribas Easy Energy &.. 8.55 % 0.00 %

+0.27 (+0.82%)

USD 0.47B
EMEH:SW BNP Paribas Easy Energy &.. 8.55 % 0.00 %

N/A

N/A
CURG:LSE VanEck Genomics and Healt.. 8.40 % 0.00 %

+0.13 (+0.82%)

USD 7.04M
CURE:XETRA VanEck Genomics and Healt.. 8.30 % 0.00 %

+0.18 (+0.82%)

N/A
2B70:F iShares NASDAQ US Biotech.. 8.28 % 0.00 %

N/A

USD 0.52B
BTEC:SW iShares Nasdaq US Biotech.. 8.28 % 0.00 %

-0.03 (0.82%)

N/A
2B70:XETRA iShares Nasdaq US Biotech.. 7.89 % 0.00 %

+0.03 (+0.82%)

USD 0.52B
PJP Invesco Dynamic Pharmaceu.. 6.18 % 0.56 %

-0.46 (0.82%)

N/A
PINK Simplify Exchange Traded .. 5.09 % 0.00 %

-0.01 (0.82%)

USD 0.18B
HHL:CA Harvest Healthcare Leader.. 5.06 % 1.15 %

-0.08 (0.82%)

N/A
PBE Invesco Dynamic Biotechno.. 5.05 % 0.57 %

-0.26 (0.82%)

N/A
SPQH:XETRA Global X S&P 500® Quarte.. 4.95 % 0.00 %

+0.11 (+0.82%)

USD 0.05B
ZWHC:CA BMO Covered Call Health C.. 4.73 % 0.00 %

N/A

N/A
UBIO 4.54 % 0.95 %

N/A

N/A
XDNA:CA 4.42 % 0.00 %

N/A

N/A
EGUSAS:SW UBS (Irl) Fund Solutions .. 4.35 % 0.00 %

N/A

USD 0.08B
MEDX Horizon Kinetics Medical .. 4.26 % 0.00 %

-0.15 (0.82%)

N/A
HEAL:CA 3.97 % 0.00 %

N/A

N/A
FTXH First Trust Nasdaq Pharma.. 3.89 % 0.60 %

-0.40 (0.82%)

USD 0.02B
SYNB Putnam Biorevolution ETF 3.83 % 0.00 %

+0.24 (+0.82%)

USD 5.43M
ENTR ERShares Entrepreneurs ET.. 3.78 % 0.49 %

+0.40 (+0.82%)

USD 0.09B
FDG American Century ETF Trus.. 3.60 % 0.00 %

+3.09 (+0.82%)

N/A
PVAL Putnam Focused Large Cap .. 3.12 % 0.29 %

+0.29 (+0.82%)

USD 0.74B
PTH Invesco DWA Healthcare Mo.. 2.85 % 0.60 %

+0.36 (+0.82%)

USD 0.14B
JPEF JPMorgan Equity Focus ETF 2.81 % 0.00 %

+1.01 (+0.82%)

USD 0.56B
CURE:AU ETFS S&P Biotech ETF 2.74 % 0.00 %

+0.16 (+0.82%)

USD 0.04B
CGGR Capital Group Growth ETF 2.46 % 0.00 %

+0.68 (+0.82%)

USD 6.28B
CAPS:LSE First Trust Capital Stren.. 2.26 % 0.00 %

+16.25 (+0.82%)

N/A
XLVE:CA Mulvihill U.S. Health Car.. 1.84 % 0.00 %

N/A

N/A
XMLH:XETRA L&G Healthcare Breakthrou.. 1.75 % 0.00 %

+0.06 (+0.82%)

USD 0.07B
XMLH:F Legal & General Ucits Etf.. 1.75 % 0.00 %

+0.07 (+0.82%)

USD 0.07B
DOCT:SW L&G Healthcare Breakthrou.. 1.75 % 0.00 %

N/A

USD 0.07B
LABU Direxion Daily S&P Biotec.. 1.52 % 1.14 %

+0.69 (+0.82%)

USD 1.11B
ULVM VictoryShares US Value Mo.. 1.24 % 0.20 %

+0.44 (+0.82%)

USD 0.16B
FLXU:LSE Franklin LibertyQ U.S. Eq.. 1.07 % 0.00 %

+0.35 (+0.82%)

USD 0.09B
FRUE:LSE Franklin LibertyQ U.S. Eq.. 1.07 % 0.00 %

+0.51 (+0.82%)

USD 0.10B
SMRT:PA 0.57 % 0.00 %

N/A

N/A
SM8T:XETRA Amundi Index Solutions - .. 0.57 % 0.00 %

+5.00 (+0.82%)

USD 0.04B
SMRU:PA Amundi Index Solutions - .. 0.57 % 0.00 %

+6.24 (+0.82%)

USD 3.35M
ACWV 0.00 % 0.20 %

N/A

N/A
BBH VanEck Biotech ETF 0.00 % 0.35 %

+0.02 (+0.82%)

USD 0.44B
BIB ProShares Ultra Nasdaq Bi.. 0.00 % 0.95 %

-0.24 (0.82%)

USD 0.09B
BIS ProShares UltraShort Nasd.. 0.00 % 0.95 %

+0.07 (+0.82%)

USD 2.95M
FBT First Trust NYSE Arca Bio.. 0.00 % 0.57 %

+1.39 (+0.82%)

N/A
FPX First Trust US Equity Opp.. 0.00 % 0.59 %

+1.94 (+0.82%)

N/A
FTCS First Trust Capital Stren.. 0.00 % 0.60 %

+0.27 (+0.82%)

USD 8.60B
IBB iShares Biotechnology ETF 0.00 % 0.47 %

+0.09 (+0.82%)

USD 7.71B
LABD Direxion Daily S&P Biotec.. 0.00 % 1.00 %

-0.02 (0.82%)

USD 0.12B
PXLG Invesco S&P 500 GARP ETF 0.00 % 0.39 %

+1.19 (+0.82%)

N/A
TPLC Timothy Plan US Large/Mid.. 0.00 % 0.00 %

+0.22 (+0.82%)

USD 0.23B
HHL-U:CA Harvest Healthcare Leader.. 0.00 % 0.00 %

-0.06 (0.82%)

N/A
HERS-B:CA 0.00 % 0.00 %

N/A

N/A
BTEC:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

+0.05 (+0.82%)

N/A
BTEK:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

+0.02 (+0.82%)

N/A
BIOT:LSE L&G PHARMA BREAKTHROUGH G.. 0.00 % 0.00 %

+0.05 (+0.82%)

N/A
BTEE:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

+0.04 (+0.82%)

N/A
XBI SPDR® S&P Biotech ETF 0.00 % 0.35 %

+0.07 (+0.82%)

N/A
XMW:CA iShares MSCI Min Vol Glob.. 0.00 % 0.48 %

+0.17 (+0.82%)

CAD 0.18B
XMY:CA iShares MSCI Min Vol Glob.. 0.00 % 0.48 %

+0.14 (+0.82%)

N/A
ZBIO 0.00 % 0.95 %

N/A

N/A
HERS:CA 0.00 % 0.62 %

N/A

N/A
FPX:LSE First Trust Global Funds .. 0.00 % 0.00 %

+51.50 (+0.82%)

N/A
SMRG:LSE 0.00 % 0.00 %

N/A

N/A
SMRU:LSE Amundi Index Solutions - .. 0.00 % 0.00 %

+6.54 (+0.82%)

N/A
VMOM:LSE 0.00 % 0.00 %

N/A

N/A
EMEH:F BNP Paribas Easy Energy &.. 0.00 % 0.00 %

N/A

N/A
GSDE:F BNP Paribas Easy Energy &.. 0.00 % 0.00 %

+0.18 (+0.82%)

N/A
SM8T:F Amundi Index Solutions - .. 0.00 % 0.00 %

+7.00 (+0.82%)

N/A
BIOT 0.00 % 0.00 %

N/A

N/A
NVQ 0.00 % 0.00 %

N/A

N/A
DWEQ 0.00 % 0.00 %

N/A

N/A
LYFE 0.00 % 0.00 %

N/A

N/A
HHL-B:CA Harvest Healthcare Leader.. 0.00 % 0.00 %

-0.09 (0.82%)

N/A
STNC Stance Equity ESG Large C.. 0.00 % 0.00 %

+0.16 (+0.82%)

USD 0.11B
AGNG Global X Aging Population.. 0.00 % 0.00 %

-0.05 (0.82%)

USD 0.06B
TDOC:CA TD Global Healthcare Lead.. 0.00 % 0.00 %

+0.01 (+0.82%)

CAD 0.09B
IBBQ Invesco Nasdaq Biotechnol.. 0.00 % 0.00 %

+0.02 (+0.82%)

USD 0.04B
TPLE Timothy Plan - Timothy Pl.. 0.00 % 0.00 %

+0.13 (+0.82%)

USD 0.07B
GSCE:SW BNP Paribas Easy Energy &.. 0.00 % 0.00 %

N/A

USD 0.27B
GSCU:SW BNP Paribas Easy Energy &.. 0.00 % 0.00 %

+0.30 (+0.82%)

USD 0.17B

Market Performance

  Market Performance vs. Industry/Classification (Biotechnology) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 21.83% 75% C 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 21.83% 75% C 83% B
Trailing 12 Months  
Capital Gain 49.09% 84% B 90% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 49.09% 84% B 90% A-
Trailing 5 Years  
Capital Gain 266.12% 92% A 93% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 266.12% 92% A 93% A
Average Annual (5 Year Horizon)  
Capital Gain 25.02% 77% C+ 82% B
Dividend Return 25.02% 77% C+ 82% B
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 27.95% 90% A- 65% D
Risk Adjusted Return 89.50% 99% N/A 95% A
Market Capitalization 42.08B 100% F 99% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Biotechnology) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 60.10 19% 30%
Price/Book Ratio 3.82 39% 28%
Price / Cash Flow Ratio 25.21 3% 11%
Price/Free Cash Flow Ratio 19.42 2% 13%
Management Effectiveness  
Return on Equity 15.28% 98% 85%
Return on Invested Capital 14.45% 88% 84%
Return on Assets 7.74% 98% 92%
Debt to Equity Ratio 7.63% 57% 74%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.